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Abstract The direct reaction of seven pyridinium oxi-
mes with the organophosphorus compounds (OPCs)
crotylsarin, cyclosarin, and VX was studied by spectro-
photometry. This method allows to quantify diVerent
parameters: (a) the half-life times (t1/2) of the oxime-
OPC reactions on the basis of the changes in the absorp-
tion at the zwitterion (betaine) peak maximum, (b) the
Wrst- and second-order rate constants (k1, k2), and (c)
the maximum reaction velocities (vmax). The results of
the study show that the reaction velocity of the nerve
agents with any of the oximes investigated decreased in
the order crotylsarin > cyclosarin > VX. The comparison
of the reaction rates of the three therapeutically used
oximes (2-PAM, obidoxime, HI 6) with the respective
OPC gave the highest rate for crotylsarin and cyclosarin
with obidoxime and to a similar degree with HI 6, while
in the case of VX the most reactive oxime was HI 6. The
reaction velocity of the nerve agents with the monopy-
ridinium oxime 2-PAM was lower as compared to the
bispyridinium oximes (obidoxime, HI 6). The results
obtained with the two sarin analogues indicate that the
direct reaction with 2-PAM, obidoxime, or HI 6 could
be used for non-corrosive decontamination purposes,
especially, if sensitive biological surfaces like skin,
mucous membranes, or wounds are considered. How-
ever, in view of the concentrations of nerve agents and
oximes, which could be expected during OPC poisoning
in man, the maximum reaction velocities would not be
high enough to contribute markedly to the detoxication
of nerve agents in vivo.
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Introduction
The fatal eVect of poisoning by organophosphorus
compounds (OPCs) like pesticides or chemical warfare
agents is due to inhibition of the active site of the
enzyme acetyl-cholinestrase (EC 3.1.1.7). Today it is
generally accepted (Volans 1996; Lee 2003) that the
treatment of OPC-poisoning is based on the immediate
and simultaneous administration of an antimuscarinic
(e.g. atropine), a reactivator (pyridinium oximes like 2-
PAM or obidoxime), and an anticonvulsant (e.g. diaze-
pam). In a biological environment (aqueous solution,
pH 7.4) pyridinium oximes form a zwitterion (betaine)
with a high electron density at the O-atome of the oxi-
mate group. This enables the oximate to react as a
nucleophilic agent and to displace the phosphyl (phos-
phonyl or posphoryl) residue from the enzyme.
Thereby a phosphyloxime (POX) intermediate is gen-
erated. Furthermore, oximes are able to react sponta-
neously with a free OPC also forming a POX. This
more or less stable intermediate is decomposed sponta-
neously into less toxic reaction products.
After the Wrst description of the direct reaction of
diVerent PAM isomers with sarin by Green and Saville
1956, various attempts have been made to characterize
and to quantify the reaction. However, the studies are
hardly to compare, since the authors did not only use
diVerent methods, OPCs, and oximes, but also diVerent
buVers, pH values, temperatures, and reactant concen-
trations (Hackley et al. 1959; Lamb et al. 1965; Okonek
1972; Nenner 1974; Harvey et al. 1986; Waser et al.
G. Becker · A. Kawan · D. Gutzeit · F. Worek (&) · L. Szinicz
Institut für Pharmakologie und Toxikologie der Bundeswehr, 
Neuherbergstrasse 11, 80937 München, Germany
e-mail: Franzworek@Bundeswehr.org123
416 Arch Toxicol (2007) 81:415–4201992). Therefore, experiments were carried out to
study the interaction of OPCs and oximes under identi-
cal conditions. In a previous communication in this
journal we reported upon the direct reaction of seven
pyridinium oximes (2-PAM, obidoxime, HS 6, HGA 1,
HGG 12, HI 6, and HLö 7) with the OPCs sarin,
soman, and tabun (Becker et al. 1997). This work was
continued and is presented here giving the results of
the interaction studies of the same seven pyridinium
oximes with the OPCs cyclosarin, crotylsarin, and VX.
Taken together, experiments with 42 diVerent combi-
nations of oximes and OPCs were carried out and
described. Since these studies were performed under
identical conditions (spectrophotometry, 0.1 M MOPS
buVer, pH 7.4 at 25°C, oxime 15 M, nerve agent
1.5 mM), the results are comparable.
The aim of the work was to elucidate whether the
direct reaction could contribute to the therapeutic
eVect of oxime treatment after OPC-poisoning. Fur-
thermore, there was the question whether the oximes
could serve as non-corrosive decontaminating com-
pounds, especially for sensitive biological surfaces like





rin, > 98% pure), and O-Ethyl S-2-(diisopropyla-
mino)ethyl methylphosphonothiolate (VX, 98% pure)
were made available by the German Ministry of
Defence (purity checked by gas chromatography).
Morpholinopropanesulfonic acid (MOPS) and pyridi-
nium-2-aldoxime methiodide (2-PAM iodide or pra-
lidoxime iodide) were obtained from Sigma
(Deisenhofen, Germany).
HGG 12 (pyridinium, 1-[[3-(benzoyl-pyridinio)meth-
oxy]methyl]-2-[(hydroxyimino)methyl]dichloride or dini-
trate) and obidoxime (1,1-[oxy-bis(methylene)]bis
[4-(hydroxyimino)methyl]pyridinium dichloride) were
obtained from Merck (Darmstadt, Germany). HI 6
(pyridinium, 1-[[[4-(aminocarbonyl)pyridinio]meth-
oxy]methyl]-2-[(hydroxyimino)methyl]dichloride) was a
gift of Dr. J. G. Clement (DRES, Ralston, Alberta, Can-
ada). HLö 7 (pyridinium, 1-[[[4-(aminocarbonyl)pyrid-
inio]methoxy]methyl]-2,4-bis[(hydroxyimino)methyl]
dimethanesulfonate) was obtained from J. Braxmeier
(Chemisches Laboratorium, Döpshofen, Germany).
HGA 1 (3-(N,N-dimethylamino-carbonyloxy)-2-(hydr
oxyiminomethyl)-1-methylpyridinium iodide) was
synthesized by Dr. H. Eckert (Institut für Organische
Chemie I, TU München, Germany), and HS 6 (pyridi-
nium, 1-[[[3-(aminocarbonyl)pyridinio]methoxy]methy
l]-2-[(hydroxyimino)methyl]dichloride) was obtained
from Dr. H. Oldiges (Fraunhofer-Institut für
Umweltchemie und Ökotoxikologie, Schmallenberg,
Germany).
Solutions
Stock solutions of the oximes (30 M) and OPCs
(3 mM crotylsarin, cyclosarin, or VX) were freshly pre-
pared in 0.1 M MOPS buVer, pH 7.4 at 25°C immedi-
ately before use. To facilitate the dispersion and
solution of VX in the buVer, the preparation was
shaken for 2 min by means of a Vortex mixer (Vortex
Genie 2, step 6).
UV spectra
The oxime spectra (250–430 nm) were recorded using a
1-cm quartz cuvette and a UV-VIS Beckman type DU
70 instrument with temperature control. The reference
spectrum of 15 M oxime (in the absence of OPC) was
determined in 0.1 M MOPS buVer, pH 7.4 at 25°C.
Immediately after mixing of 1.5 ml of oxime solution
with 1.5 ml of the OPC stock solution in the quartz
cuvette, the reaction spectra, i.e. the time dependent
changes of the oxime concentrations were followed at
25°C after various reaction time intervals (0.25–
540 min). At the start of the reaction the Wnal concentra-
tions of each of the oximes and OPCs were 15 M and
1.5 mM, respectively, i.e. the oxime to OPC ratio was
1:100. In the spectral region of interest neither MOPS
buVer nor the OPCs showed any absorbance. The peak
absorbance in the region of interest (250 nm–400 nM),
representing the zwitterionic (betaine) form of the
oxime (Schoene 1973; Waser et al. 1992), was used for
quantiWcation and calculation of the decomposition half-
life times t1/2, the Wrst-order rate constants k1, the sec-
ond-order rate constants k2, and the maximum reaction
velocities vmax at the reactant concentrations indicated.
Calculations
The semilogarithmic plot of oxime concentrations ver-
sus time showed a straight line indicating a monomo-
lecular reaction (pseudo-Wrst-order kinetics). After the
graphic determination of the half-life time t1/2 the Wrst-
order rate constant k1 is available, since at that point of
time the initial oxime concentration is reduced to ½:
k1 £ t1/2 = ¡ln ½ = ¡2.303 log ½123
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for practical use: k1 = 0.693/t1/2 (min
¡1)
k1 leads to the second-order rate constant k2: 
k2 = k1/(initial OPC concentration) = k1/1.5 £ 10¡3
(M¡1 min¡1)
By means of k2 the maximum reaction velocity can be
calculated:
vmax = k2 £ (oxime concentration) £ (OPC con-
centration) (M min¡1)
vmax = k2 £ (15 £ 10¡6) £ (1.5 £ 10¡3) (M min¡1)
for practical use: vmax = k2 £ 22.5 £ 10¡9 (M
min¡1)
All kinetic parameters summarized in Table 1 were
calculated this way.
Results
The direct reaction of the oxime HI 6 and crotylsarin is
shown in Fig. 1. The spectrum of HI 6 (reference in the
absence of crotylsarin) is characterized by three max-
ima at 273, 300, and 354 nm, respectively. After addi-
tion of an 100-fold excess of crotylsarin, a marked but
transient increase of the peak at 273 nm over a period
of 10 min could be observed, whereas the two other
maxima decreased. The half-time of HI 6 concentra-
tion decrease was 3.7 min according the diminution of
the zwitterion peak at 354 nm.
Figure 2 shows the direct reaction of HI 6 and VX. It
is obvious that the change of the HI 6 spectrum was
diVerent, compared to the experiments with crotylsa-
rin. The maxima at 300 and 354 nm decreased similar
to the experiments with crotylsarin, whereas the peak
at 273 nm was transformed into a shoulder. On the
basis of the decreasing absorbances at 354 nm the half-
life time of HI 6 decrease was determined to be
16.4 min.
The spectrum of 2-PAM (reference in the absence
of cyclosarin) displays a peak at 294 nm and a shoulder
(zwitterion) at 330 nm (Fig. 3). After addition of an
100-fold excess of cyclosarin the maximum and the
shoulder decreased with increasing reaction time. The
Table 1 Decomposition half-lifes (t1/2), rate constants (k1, k2), and maximum reaction velocities (vmax) of diVerent oximes (15 M) in
the presence of 1.5 mM of crotylsarin, cyclosarin, or VX in 0.1 M MOPS buVer, pH 7.4 at 25°C
Calculations are on the basis of the absorbances at the wavelengths indicated in parentheses. The full chemical name of the oximes is
given in Materials and methods
Oxime Poison t1/2 (min) k1 (min
¡1) k2 (M
¡1 min¡1) vmax (M min
¡1)






















































































































































418 Arch Toxicol (2007) 81:415–420peak at 294 nm showed a hypsochromic shift during
the incubation time, while the shoulder was stationary.
The half-life time of 2-PAM was 7.5 min (294 nm) or
6.0 min (326 nm), respectively.
The experimental results and the calculated kinetic
parameters are summarized in Table 1. As the dimen-
sion (min¡1) of k1 in Table 1 shows, this value charac-
terizes the decay of a substance (OPC) per minute. The
Wrst-order rate constant k1 is independent of the con-
centration. The multiplication of k1 with 100 gives the
percentage of decay per minute; for example, the Wrst
line in Table 1 shows a k1 value of 0.1307 min
¡1, that
means a disappearance per minute of 13.07% of cro-
tylsarin. In contrast to k1 the second-order rate con-
stant k2 is dependent on the concentration. The
knowledge of k2 is necessary for the calculation of the
maximum reaction velocity vmax. This parameter can-
not be exceeded and describes the maximum quantity
of a substance (moles per litre) that react per minute.
It can be taken from Table 1 that the reaction veloc-
ities increased in the order VX < cyclosarin
< crotylsarin. The reaction of VX and HGA 1 was
too slow (t1/2 > 540 min) to calculate a half-time.
Even the doubling of the VX concentration from 1.5
to 3.0 mM did not increase the reaction velocity. The
same phenomenon was to be observed (t1/2 > 540 min)
with the reaction of VX and HLö 7 (354 nm;
Table 1).
Discussion
The results indicate that the oximes investigated react
spontaneously with the three OPCs. The reaction
velocities, however, were markedly diVerent. The sarin
analogues showed high reaction velocities with half-
times of the oximes between 3.5 and 9.1 min (crotylsa-
rin) and between 5.8 and 12.2 min (cyclosarin). In con-
trast, the decrease of the oxime concentration was
much slower in the presence of VX (half-times
Fig. 1 Time related spectral changes of a mixture of HI 6 (15 M)
and crotylsarin (1.5 mM) in 0.1 M MOPS buVer, pH 7.4 at 25°C.
Time of recording relative to the reaction start by mixing of the
components (HI 6, 30 M + crotylsarin, 3 mM, in 0.1 M MOPS
buVer, 1.5 ml each) given in minutes. For the full chemical name
of the oxime see Materials and methods
Fig. 2 Time related spectral changes of a mixture of HI 6 (15 M)
and VX (1.5 mM) in 0.1 M MOPS buVer, pH 7.4 at 25°C. Time of
recording relative to the reaction start by mixing of the compo-
nents (HI 6, 30 M + VX, 3 mM, in 0.1 M MOPS buVer, 1.5 ml
each) given in minutes. For the full chemical name of the oxime
see Materials and methods
Fig. 3 Time related spectral changes of a mixture of 2-PAM
(15 M) and cyclosarin (1.5 mM) in 0.1 M MOPS buVer, pH 7.4 at
25°C. Time of recording relative to the reaction start by mixing of
the components (2-PAM, 30 M + cyclosarin, 3 mM, in 0.1 M
MOPS buVer, 1.5 ml each) given in minutes. For the full chemical
name of the oxime see Materials and methods123
Arch Toxicol (2007) 81:415–420 419between 16.4 and 151 min). In two cases, HGA 1 at
340 nm and HLö 7 at 354 nm, the direct reaction with
VX was too slow to calculate half-lifes of the oximes
(t1/2 > 540 min). The explanation might be that the
leaving group of the sarin analogues is the small Xuo-
ride ion (MW ca. 19 Da) whereas the leaving group of
VX (the anion of diisopropylaminothioethanol) shows
more than the eightfold mass (MW ca. 160 Da). Other
reasons for the diVerent behaviour of the sarin ana-
logues and VX might be diVerent water solubility,
diVerent electron density at the P-atome, and steric
factors.
The direct reaction is accomplished at least in three
steps, (a) generation of the oxime zwitterion (betaine),
(b) formation of a phosphyloxime (POX) intermedi-
ate, and (c) irreversible decomposition of the POX into
less toxic compounds (Steinberg and Solomon 1966).
POXs were identiWed as highly toxic anticholinester-
ases, even 10- to 100-fold more toxic than their parent
compounds (Hackley et al. 1959; Lamb et al. 1964,
1965; Schoene 1973; Nenner 1974; de Jong and Ceulen
1978; Harvey et al. 1984, 1986; Worek et al. 2000). The
stability of the POX intermediate seems to be an
important factor determining the velocity of the direct
reaction. During the reaction of HI 6 and crotylsarin,
an immediate increase followed by a diminution of the
peak at 273 nm was observed (Fig. 1). This could be
interpreted as formation and degradation of a metasta-
ble transition state complex in which the POX and
other reaction products are involved. In the same way
the alteration of the HI 6 spectrum at 273 nm during
the reaction with VX (Fig. 2) and the marked hypso-
chromic shift during the reaction of 2-PAM and cyclos-
arin (Fig. 3) could be explained.
Recently, Ashani et al. (2003) reported upon the dis-
tinctive properties of the POXs formed from 2-, 3-, and
4-PAM with diVerent OPCs (e.g. sarin, cyclosarin,
soman, tabun, VX). The t1/2 values of the non-enzy-
matic decomposition of the 2-PAM POXs ranged from
0.7 to 1.5 min. We observed similar half-lifes from 3.9
to 7.5 min for the complete direct reaction (formation
and decomposition of the POXs) of cyclo- or crotylsa-
rin with 2-PAM. However, our results obtained with 2-
PAM and VX at 294 and 326 nm show much higher
values (t1/2 > 60 min). The reason for this diVerence
might be the leaving group eVect during POX forma-
tion mentioned above. Furthermore, it must be taken
in account that Ashani et al. (2003) worked with highly
diluted HEPES buVer (0.01 M), pH 7.8 at 29°C. The
concentration of the POXs was in the order of magni-
tude of 0.05 mM (=50 M) as described in an earlier
paper of this group (Leader et al. 1999). Compared to
the conditions we used (0.1 M MOPS buVer, pH 7.4 at
25°C; 15 M oxime and 1.5 mM nerve agent), the
diVerent buVer type and buVer concentration, pH
value, and reaction temperature may have an acceler-
ating eVect on the decomposition velocity of the POXs
and may explain the short half-times given by Ashani
et al. (2003).
The question whether the direct reaction could con-
tribute to the detoxication of nerve agents in vivo dur-
ing OPC poisoning can be evaluated by means of the
maximum reaction velocities (vmax) in Table 1. These
values reach from 0.070 £ 10¡6 to 2.970 £
10¡6 M min¡1, hence, the pair HLö 7/VX shows the
lowest and the combination obidoxime/crotylsarin the
highest reaction velocity (Table 1). It can be assumed
that during poisoning the OPC concentration in vivo is
in the nanomolar range and the reasonable therapeutic
concentration of an oxime is approximately 15 M.
Under these conditions the maximum reaction veloci-
ties are vmax = 0.465 £ 10¡12 M min¡1 (at 10 nM VX
and 15 M HI 6) and vmax = 19.80 £ 10¡12 M min¡1 (at
10 nM crotylsarin and 15 M obidoxime).
The vmax values of all the other OPC oxime combi-
nations in Table 1 are to be found within this range.
These results are in agreement with a previous study
(Becker et al. 1997) using soman/HI 6. In this case the
maximum reaction velocity was calculated to be
vmax = 2.55 £ 10¡12 M min¡1 (at 10 nM soman and
15 M HI 6). This order of magnitude (picomoles per
litre) demonstrates that the direct reaction cannot
markedly contribute to the therapeutic eVect of oximes
in vivo.
Conclusion
The results presented here with crotyl- and cyclosarin
demonstrate that the direct reaction of OPCs and
pyridinium oximes could be used for mild decontami-
nation/detoxication purposes (skin, mucous mem-
branes, wounds). Pyridinium oximes could substitute
the eYcient but corrosive preparations of hypochlo-
rites (NaOCl solution, calcium hypochlorite/magne-
sium oxide powder). This holds true for previously
published data obtained with sarin, soman, and tabun
(Becker et al. 1997). For practical administrations it
might be useful to accelerate the third step of the direct
reaction, i.e., the degradation of the POXs, by addition
of bacterial (Ashani et al. 1998; Leader et al. 1999;
HerkenhoV et al. 2004) or human plasma enzymes
(Kiderlen et al. 2000; Worek et al. 2000).
The importance of the direct reaction in the detoxi-
cation during human OPC poisoning may be assessed
by considering the generated data (Table 1) and by123
420 Arch Toxicol (2007) 81:415–420regarding the concentrations of OPCs and oximes,
which can be expected in human OPC poisoning.
Hence, the maximum reaction velocity was calculated
to be in the range of 10¡12 M min¡1 (picomoles per
litre). This demonstrates that in vivo the direct reaction
is only of small signiWcance. However, it can be consid-
ered as a beneWcial side eVect to the oxime action in
vivo.
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